Clearwater Paper Reports Q1 Loss Below Estimates, Boosted by $17.5M Insurance Recovery
summarizeSummary
Clearwater Paper reported a Q1 net loss of $0.80 per share, outperforming analyst estimates, primarily due to a $17.5 million insurance settlement that mitigated operational declines and weather impacts.
check_boxKey Events
-
Q1 Loss Beats Analyst Estimates
The company reported a net loss of $0.80 per share for Q1 2026, significantly better than the Reuters consensus estimate of a $1.32 loss per share and Dow Jones' adjusted loss of $1.29 per share.
-
Significant Insurance Recovery
Clearwater Paper received a $17.5 million partial settlement from a representation and warranty insurance policy related to the Augusta acquisition, with $11.9 million recorded as income in 'Other operating charges, net'.
-
Operational Performance Decline
Net sales decreased by 5% to $360.3 million, and Adjusted EBITDA from continuing operations fell 94% to $1.9 million compared to Q1 2025, primarily due to cold weather events and market price decreases.
-
Cost Reduction Efforts Underway
Selling, general and administrative expenses decreased by 29% due to planned cost reduction initiatives. The company also announced new cost reduction and production curtailment plans at its Cypress Bend facility, targeting $8 million to $12 million in annualized savings.
auto_awesomeAnalysis
Clearwater Paper's first-quarter results showed a net loss of $0.80 per share, which was significantly better than analyst expectations of a $1.32 loss per share. This beat was largely driven by a substantial $17.5 million partial settlement from a representation and warranty insurance policy related to the Augusta acquisition, which materially offset operational challenges. While net sales decreased by 5% and Adjusted EBITDA from continuing operations saw a sharp 94% decline year-over-year, attributed partly to severe weather events and market-driven price decreases, the company demonstrated progress in cost reduction, with SG&A expenses decreasing by 29%. The company also announced further cost reduction and production curtailment plans at its Cypress Bend facility, expected to yield $8 million to $12 million in annualized savings. Liquidity remains stable with an increased cash balance and significant borrowing capacity. However, the outlook for Q2 2026 includes expectations for higher operating costs due to planned major maintenance and increased input costs, alongside a new PFAS-related environmental lawsuit, which introduces a long-term risk.
At the time of this filing, CLW was trading at $14.85 on NYSE in the Manufacturing sector, with a market capitalization of approximately $238.2M. The 52-week trading range was $12.44 to $30.96. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.